Germany gave the green light for human trials of potential coronavirus vaccines developed by German biotech company BioNTech, which is racing teams in Germany, the U.S. and China to develop an agent that will stop the pandemic.
The trial, only the fourth worldwide of a vaccine targeting the virus, will be initially conducted on 200 healthy people, with more subjects, including some at higher risk from the disease, to be included in a second stage, German vaccines regulator the Paul Ehrlich Institut said on Wednesday.
Tests of the vaccine were also planned in the United States, once regulatory approval for testing on humans had been secured there.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Germany Is Conducting Nationwide COVID-19 Antibody TestingGermany has been testing for COVID-19 on a greater scale than most countries: an estimated 120,000 tests a day. Now it's launching Europe first large-scale antibody testing, an attempt to get accurate infection and immunity data from across the country.
Consulte Mais informação »
More Than 400K L.A. County Residents May Have Been Infected With COVID-19, Per Antibody StudyAnywhere between 221,000 and 442,000 L.A. County residents could have been infected with the COVID19 illness per a newly released antibody study
Consulte Mais informação »
How a Legal Brothel Worker Is Selling the 'Girlfriend Experience' During COVID-19 PandemicHow a Legal Brothel Worker Is Selling the ‘Girlfriend Experience’ During COVID-19 Pandemic
Consulte Mais informação »
Disinfectant-Linked Poisoning Rises Amid COVID-19
Consulte Mais informação »
6 Ways to Deal with Selfish People During COVID-19How beginning to understand some of the unintentional reasons for selfish behavior can help us be more tolerant in these difficult times
Consulte Mais informação »
COVID-19 Changes Funerals and How Families GrieveSome families, especially in coronavirus hot spots, are having to postpone funerals as the funeral industry struggles to keep up with the sheer volume of COVID-19 deaths.
Consulte Mais informação »